Carisma Therapeutics Inc. (CARM) — Capital Reinvestment Ratio

Latest as of March 2022: 0.03x

Carisma Therapeutics Inc. (CARM) has a Capital Reinvestment Ratio of 0.03x as of March 2022, meaning it reinvests 0% of its operating cash flow ($34.60 Million) in capital expenditures ($1.01 Million). See how leveraged is Carisma Therapeutics Inc.'s balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$34.60 Million

USD

Capital Expenditures

$1.01 Million

USD

Data as of

Mar 2022

Most recent filing

Annual Capital Reinvestment Ratio for Carisma Therapeutics Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Carisma Therapeutics Inc. from None to None. For live market cap and broader valuation context, see Carisma Therapeutics Inc. stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow